ReviewCancer biology & medicine2026

Opportunities and challenges of immunotherapy for patients with resectable and potentially resectable stage III non-small cell lung cancer.

Yuzhen Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.